Promoter hypermethylation in sentinel lymph nodes as a marker for breast cancer recurrence

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Breast Cancer Research and Treatment

• Publication date

  2009-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s10549-008-0004-7PMID 18404369PMCID PMC3422075
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cancer Statistics, 2007

  2007cited by this paper
• Surgical Removal of the Primary Tumor Increases Overall Survival in Patients With Metastatic Breast Cancer: Analysis of the 1988–2003 SEER Data

  2007cited by this paper
• Editorial

  2007cited by this paper
• The impact of nodal isolated tumor cells on survival of breast cancer patients.

  2007cited by this paper
• Relationship between lymph node metastasis and E-cadherin expression in submucosal invasive gastric carcinomas with gastric-phenotype.

  2007cited by this paper
• Hypermethylation of ASC/TMS1 is a sputum marker for late-stage lung cancer.

  2006cited by this paper
• CDH1 promoter hypermethylation and E-cadherin protein expression in infiltrating breast cancer

  2006cited by this paper
• Axillary sentinel lymph nodes can be falsely positive due to iatrogenic displacement and transport of benign epithelial cells in patients with breast carcinoma.

  2006cited by this paper
• Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer.

  2006cited by this paper
• Biological Significance of Occult Micrometastases in Histologically Negative Axillary Lymph Nodes in Breast Cancer Patients Using the Recent American Joint Committee on Cancer Breast Cancer Staging System

  2006cited by this paper
• REporting recommendations for tumor MARKer prognostic studies (REMARK)

  2006cited by this paper
• Distinct Hypermethylation Profile of Primary Breast Cancer Is Associated with Sentinel Lymph Node Metastasis

  2005cited by this paper
• Genetic and epigenetic changes in mammary epithelial cells identify a subpopulation of cells involved in early carcinogenesis.

  2005cited by this paper
• High frequency of promoter hypermethylation of RASSF1A in tumorous and non‐tumourous tissue of breast cancer

  2005cited by this paper
• Promoter hypermethylation in benign breast epithelium in relation to predicted breast cancer risk.

  2005cited by this paper
• Modes of Benign Mechanical Transport of Breast Epithelial Cells to Axillary Lymph Nodes

  2005cited by this paper
• REporting recommendations for tumor MARKer prognostic studies (REMARK)

  2005cited by this paper
• Hypermethylation of a Small CpGuanine-Rich Region Correlates with Loss of Activator Protein-2α Expression during Progression of Breast Cancer

  2004cited by this paper
• Epigenetics in human disease and prospects for epigenetic therapy

  2004cited by this paper
• Effects of dietary folate and alcohol intake on promoter methylation in sporadic colorectal cancer: the Netherlands cohort study on diet and cancer.

  2003influential reference
• Breast cancer classification and prognosis based on gene expression profiles from a population-based study

  2003cited by this paper
• Evaluation of immunohistochemistry and multiple-level sectioning in sentinel lymph nodes from patients with breast cancer.

  2003cited by this paper
• A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer.

  2003cited by this paper
• DNA methylation and breast carcinogenesis

  2002cited by this paper
• A gene-expression signature as a predictor of survival in breast cancer.

  2002cited by this paper
• Gene expression profiling predicts clinical outcome of breast cancer

  2002cited by this paper
• Reactivating the expression of methylation silenced genes in human cancer

  2002cited by this paper
• Reduced nuclear expression of transcription factor AP-2 associates with aggressive breast cancer.

  2002cited by this paper
• HIN-1, a putative cytokine highly expressed in normal but not cancerous mammary epithelial cells

  2001cited by this paper
• Genes, Chromatin, and Breast Cancer: An Epigenetic Tale

  2001cited by this paper
• DNA methylation in breast cancer.

  2001cited by this paper
• Promoter hypermethylation--can this change alone ever designate true tumor suppressor gene function?

  2001cited by this paper
• Sentinel lymph node biopsy as an indicator for axillary dissection in early breast cancer.

  2001cited by this paper
• 5' CpG island methylation of the FHIT gene is correlated with loss of gene expression in lung and breast cancer.

  2001cited by this paper
• Sentinel lymph node biopsy for breast cancer: a suitable alternative to routine axillary dissection in multi-institutional practice when optimal technique is used.

  2000cited by this paper
• Benign transport of breast epithelium into axillary lymph nodes after biopsy.

  2000cited by this paper
• Relationships between chromatin organization and DNA methylation in determining gene expression.

  1999cited by this paper
• Significance of axillary lymph node metastasis in primary breast cancer.

  1999cited by this paper
• Molecular detection of neoplastic cells in lymph nodes of metastatic colorectal cancer patients predicts recurrence.

  1999cited by this paper
• The sentinel node in breast cancer--a multicenter validation study.

  1998cited by this paper
• Methylation-mediated regulation of the glutathione S-transferase P1 gene in human breast cancer cells.

  1998cited by this paper
• Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands.

  1996cited by this paper
• The new era in breast cancer.

  1996cited by this paper
• The new era in breast cancer. Invasion, size, and nodal involvement dramatically decreasing as a result of mammographic screening.

  1996cited by this paper
• E-cadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinomas.

  1995cited by this paper
• Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers.

  1995cited by this paper
• Pathologic findings from the national surgical adjuvant breast project protocol B‐06 10‐year pathologic and clinical prognostic discriminants

  1993cited by this paper
• A long-term follow-up study of survival in stage I (T1N0M0) and stage II (T1N1M0) breast carcinoma.

  1989cited by this paper
• Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases

  1989cited by this paper
• Pathologic findings from the national surgical adjuvant breast project (protocol 6) I. Intraductal carcinoma (DCIS)

  1986cited by this paper

• Promoter hypermethylation profiling of distant breast cancer metastases

  2015cites this paper
• Quantitative detection of methylated NDRG4 gene as a candidate biomarker for diagnosis of colorectal cancer

  2014cites this paper
• Breast cancer nodal metastasis correlates with tumour and lymph node methylation profiles of Caveolin-1 and CXCR4

  2014cites this paper
• Identification of inguinofemoral lymph node metastases by methylation markers in vulvar cancer.

  2012cites this paper
• Is PCR testing of sentinel lymph nodes ready for clinical application in breast cancer?

  2011cites this paper
• A study of the methylation status of opioid binding protein/cell adhesion molecule-like gene in ovarian cancer using nested methylation-specific polymerase chain reaction detection.

  2011cites this paper
• Review Article Epigenetic Studies in Human Diseases

  2010cites this paper
• Tumor suppressor genes are frequently methylated in lymph node metastases of breast cancers

  2010cites this paper
• Epigenetic studies in human diseases.

  2010cites this paper
• Acute myeloid leukemia is characterized by Wnt pathway inhibitor promoter hypermethylation

  2010cites this paper
• Epigenetic Studies in Human Diseases ( epigenetics / human diseases / methylation / histone acetylation / miRNA / cancer )

  2010cites this paper
• Cancer DNAMethylation : Molecular Mechanisms and Clinical Implications

  2009cites this paper
• Cancer DNA Methylation: Molecular Mechanisms and Clinical Implications

  2009cites this paper